Sorafenib tosylate is the first listing of approved drugs targeting multiple targets, but also over the past decade is the only FDA approved drug for the treatment of renal cell carcinoma.

June 21, 2017

prudect name : Sorafenib tosylate is the first listing of approved drugs targeting multiple targets, but also over the past decade is the only FDA approved drug for the treatment of renal cell carcinoma.
Sorafenib tosylate

Synonyms: Nexavar, Bay 43-9006CAS NO: 475207-59-1Molecular Formula: C₂₁H₁₆ClF₃N₄O₃.C₇H₈SO₃Molecular Weight: 637.03Purity: 99%Solubility: In DMSOStorage: −20°C 2 years

web site: www.medchemexpress.com